2-Pyrazinecarboxylic acid → 6-Chloro-3-(pyrazin-2-yl)-1,2,4-triazolo[3,4-a]phthalazine
反応式
[Cl:1][C:2]1[C:11]2[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=2)[C:5]([NH:12][NH2:13])=[N:4][N:3]=1.[N:14]1[CH:19]=[CH:18][N:17]=[CH:16][C:15]=1[C:20](O)=O>>[Cl:1][C:2]1[C:11]2[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=2)[C:5]2=[N:12][N:13]=[C:20]([C:15]3[CH:16]=[N:17][CH:18]=[CH:19][N:14]=3)[N:4]2[N:3]=1参加物
3
実験手順
The title-compound was prepared from 1-chloro-4-hydrazinophthalazine and pyrazine-2-carboxylic acid as described for Intermediate 1 part c, 1H NMR (250 MHz, CDCl3) δ 7.99 (1H, t, J=7.2 Hz, Ar—H), 8.09 (1H, t, J=8.2 Hz, Ar—H), 8.33 (1H, d, J=6.8 Hz; Ar—H), 8.80 (1H, m, Ar—H), 8.82-8.88 (2H, m, 2 of Ar—H), 9.67 (1H, d, J=1.5 Hz, Ar—H).
出典と根拠
- ORDレコード
- ord-c2a113d12d8e4b8bb50a1540847901e8
- 出典データセット
- uspto-grants-2001_10
- 特許番号
- US06310203B1
反応ノート
読み込み中…